Current status and future of epithelial ovarian cancer markers
Li, L.; Yang, Z.J.; Wang, Q.
Zhonghua Fu Chan Ke Za Zhi 52(1): 4-7
2017
ISSN/ISBN: 0529-567X PMID: 28190308 Document Number: 693537
Document emailed within 1 workday
Related Documents
Ozols, R.F.; Vermorken, J.B. 1997: Chemotherapy of advanced ovarian cancer: current status and future directions Seminars in Oncology 24(1 Suppl 2: S2Sparholt, M.H.; Høgdall, E.; Høgdall, C.K. 2009: Tumour markers in epithelial ovarian cancer Ugeskrift for Laeger 171(48): 3505-3509
Shelling, A.N.; Cooke, I.E.; Le Meuth, V.G.; Ganesan, T.S. 1996: Epithelial ovarian cancer: future prospects for treatment New Zealand Medical Journal 109(1020): 131-132
Djordjevic, B.; Stojanovic, S.; Conic, I.; Jankovic-Velickovic, L.; Vukomanovic, P.; Zivadinovic, R.; Vukadinovic, M. 2012: Current approach to epithelial ovarian cancer based on the concept of cancer stem cells Journal of BUON: Official Journal of the Balkan Union of Oncology 17(4): 627-636
Fujiwara, K. 2015: Current and future trend of chemotherapy for ovarian cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(2): 164-165
Demeter, A.; Sziller, I.; Csapo, Z.; Olah, J.; Keszler, G.; Jeney, A.; Papp, Z.; Staub, M. 2005: Molecular prognostic markers in recurrent and in non-recurrent epithelial ovarian cancer Anticancer Research 25(4): 2885-2889
Hanauske, A.R. 1997: UFT in gastric cancer: current status and future developments Oncology 11(9 Suppl 10: 113-118
Messadi, D.V.; Sato, K. 2016: Oral Cancer Chernoprevention: Current Status and Future Direction Journal of the California Dental Association 44(2): 101-111
Sonoo, H. 2007: Current status and future prospects for breast cancer therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 65 Suppl. 6: 391-395
Zola, H. 1992: Phenotypic markers for functional lymphocyte populations: a critical appraisal of current usage as disease markers and future prospects Disease Markers 10(2): 53-66
Sekine, M.; Yoshihara, K.; Tanaka, K. 2012: Clinical aspects of familial ovarian cancer - current status and issues in Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(4): 506-511
Okihara, K. 2016: Current status and future perspective in Japanese prostate cancer screening Nihon Rinsho. Japanese Journal of Clinical Medicine 74 Suppl. 3: 275-279
Pandian, S.S.; Eremin, O.E.; McClinton, S.; Wahle, K.W.; Heys, S.D. 1999: Fatty acids and prostate cancer: current status and future challenges Journal of the Royal College of Surgeons of Edinburgh 44(6): 352-361
Endo, K.; Yoshizaki, T. 2018: V. Supportive Management in Head and Neck Cancer - Current Status and Future Perspectives Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(7): 1061-1064
Pathak, A.K.; Bhutani, M.; Mohan, A.; Guleria, R.; Bal, S.; Kochupillai, V. 2004: Non small cell lung cancer (NSCLC): current status and future prospects Indian Journal of Chest Diseases and Allied Sciences 46(3): 191-203
Osaki, A.; Saeki, T. 2011: Current status and future direction of postoperative adjuvant therapy in breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(9): 1406-1411
Kimura, H.; Akazai, Y.; Nitta, Y. 2006: Outpatient based colorectal cancer treatment--the current status, challenges and future outlook Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(5): 606-610
Tokuda, Y. 2014: The Japanese Breast Cancer Society Breast Cancer Registry in the National Clinical Database: current status and future perspectives Nihon Geka Gakkai zasshi 115(1): 17-21
Jin, Z.; Gu, J.; Xin, X.; Li, Y.; Wang, H. 2014: Expression of hexokinase 2 in epithelial ovarian tumors and its clinical significance in serous ovarian cancer European Journal of Gynaecological Oncology 35(5): 519-524
Shima, T.; Masai, K.; Hishida, T.; Kaseda, K.; Hashimoto, K.; Takahashi, Y.; Otsuka, T.; Asamura, H. 2018: Role of Surgery in Multimodality Treatment for Non-small Cell Lung Cancer;Current Status and Future Perspectives Kyobu Geka. Japanese Journal of Thoracic Surgery 71(4): 244-248